GP's Adherence to Guidelines for Cardiovascular Disease among Elderly: A Quality Development Study

Table 3

Patients with chronic heart failure who are pharmacologically treated and investigated according to the guidelines.

		N	Percentage (95% CI)	Difference^a (95% CI)	𝑃 value
Number of patients	2006	75
	2008	94
Investigation with ECO	2006	42	56.0 (44.1, 67.5)	10.0 (−6.0, 25.9)	0.24
	2008	62	66.0 (55.5, 75.4)
Investigation with plasma NT-proBNP	2006	32	42.7 (31.3, 54.6)	46.7 (32.7, 60.7)	<10^−4
	2008	84	89.4 (81.3, 94.8)
Treated with ACEI or ARB	2006	45	60.0 (48.0, 71.1)	11.3 (−4.30, 26.9)	0.17
	2008	67	71.3 (61.0, 80.1)
ACEI recommended dose	2006	16/45	35.6 (21.9, 51.2)	−1.3 (−20.4, 18.0)	1
	2008	23/67	34.3 (23.2, 46.9)
Treated with beta-blocker	2006	22	29.3 (19.4, 41.0)	19.6 (4.0, 35.2)	0.015
	2008	46	48.9 (38.5, 59.5)

^aDifference between 2008 and 2006.